Correlation Between Fundamental Invest and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fundamental Invest and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fundamental Invest and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fundamental Invest and Genmab AS, you can compare the effects of market volatilities on Fundamental Invest and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fundamental Invest with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fundamental Invest and Genmab AS.

Diversification Opportunities for Fundamental Invest and Genmab AS

0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Fundamental and Genmab is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Fundamental Invest and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Fundamental Invest is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fundamental Invest are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Fundamental Invest i.e., Fundamental Invest and Genmab AS go up and down completely randomly.

Pair Corralation between Fundamental Invest and Genmab AS

Assuming the 90 days trading horizon Fundamental Invest is expected to generate 0.48 times more return on investment than Genmab AS. However, Fundamental Invest is 2.07 times less risky than Genmab AS. It trades about 0.12 of its potential returns per unit of risk. Genmab AS is currently generating about 0.03 per unit of risk. If you would invest  28,435  in Fundamental Invest on January 20, 2024 and sell it today you would earn a total of  1,955  from holding Fundamental Invest or generate 6.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Fundamental Invest   vs.  Genmab AS

 Performance 
       Timeline  
Fundamental Invest 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Fundamental Invest are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Fundamental Invest may actually be approaching a critical reversion point that can send shares even higher in May 2024.
Genmab AS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Genmab AS is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Fundamental Invest and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fundamental Invest and Genmab AS

The main advantage of trading using opposite Fundamental Invest and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fundamental Invest position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind Fundamental Invest and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data